Further study of the changes in cell processes and pathways in patients with PTEN mutations will contribute to further understanding of the pathogenesis of the disease and provide more novel evidence for the accurate treatment of prostate cancer. The gene discussed is PTEN; the disease is Familial prostate cancer.